156 related articles for article (PubMed ID: 7262030)
1. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
Black LJ; Goode RL
Endocrinology; 1981 Sep; 109(3):987-9. PubMed ID: 7262030
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
Jordan VC; Gosden B
Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
[TBL] [Abstract][Full Text] [Related]
3. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
Jordan VC; Gosden B
J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
[TBL] [Abstract][Full Text] [Related]
4. Molecular effects of antiestrogens (tamoxifen and LY117018) on estrogen-dependent glycoprotein (USP-1) synthesized and secreted by rat uterine epithelial cells.
Takeda A; Shimizu S
Endocrinology; 1988 Jul; 123(1):258-63. PubMed ID: 3383775
[TBL] [Abstract][Full Text] [Related]
5. The stimulation of uterine complement component C3 gene expression by antiestrogens.
Sundstrom SA; Komm BS; Xu Q; Boundy V; Lyttle CR
Endocrinology; 1990 Mar; 126(3):1449-56. PubMed ID: 2307112
[TBL] [Abstract][Full Text] [Related]
6. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
Campen CA; Jordan VC; Gorski J
Endocrinology; 1985 Jun; 116(6):2327-36. PubMed ID: 3996316
[TBL] [Abstract][Full Text] [Related]
7. Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice.
Black LJ; Goode RL
Life Sci; 1980 Apr; 26(17):1453-8. PubMed ID: 7382727
[No Abstract] [Full Text] [Related]
8. Counteraction of estradiol-induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen, LY117018.
Uchiumi T; Mizoguchi H; Hagino Y; Kohno K; Kuwano M
Int J Cancer; 1991 Jan; 47(1):80-5. PubMed ID: 1702405
[TBL] [Abstract][Full Text] [Related]
9. Differential interaction of antiestrogens with cytosol estrogen receptors.
Black LJ; Jones CD; Goode RL
Mol Cell Endocrinol; 1981 Apr; 22(1):95-103. PubMed ID: 7239000
[TBL] [Abstract][Full Text] [Related]
10. Modulation of rat uterine progesterone receptor levels and peroxidase activity by tamoxifen citrate, LY117018, and estradiol.
Keeping HS; Lyttle CR
Endocrinology; 1982 Dec; 111(6):2046-54. PubMed ID: 6890442
[No Abstract] [Full Text] [Related]
11. Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells.
Simoncini T; De Caterina R; Genazzani AR
J Clin Endocrinol Metab; 1999 Feb; 84(2):815-8. PubMed ID: 10022460
[TBL] [Abstract][Full Text] [Related]
12. In vivo activation of gene transcription via oestrogen response elements by a raloxifene analogue.
Engdahl C; Jochems C; Gustafsson JA; van der Saag PT; Carlsten H; Lagerquist MK
J Endocrinol; 2009 Dec; 203(3):349-56. PubMed ID: 19752149
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I2 production by rat liver cells.
Levine L
BMC Cancer; 2004 Aug; 4():49. PubMed ID: 15310397
[TBL] [Abstract][Full Text] [Related]
14. The antiestrogen LY117018 blocks effects of estradiol on pituitary glucose-6-phosphate dehydrogenase specific activity and on serum LH.
Gordon MN; Mobbs CV; Finch CE
Neuroendocrinology; 1985 May; 40(5):381-4. PubMed ID: 4010886
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of estrogen- and antiestrogen-induced uterine complement component C3 expression by ICI 164,384.
Galman MS; Sundstrom SA; Lyttle CR
J Steroid Biochem; 1990 Jul; 36(4):281-6. PubMed ID: 2391957
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.
Wakeling AE; O'Connor KM; Newboult E
J Endocrinol; 1983 Dec; 99(3):447-53. PubMed ID: 6644235
[TBL] [Abstract][Full Text] [Related]
17. Characterization of antiestrogen stimulation of cell number and prolactin production.
Amara JF; Dannies PS
Mol Cell Endocrinol; 1986 Oct; 47(3):183-9. PubMed ID: 3758472
[TBL] [Abstract][Full Text] [Related]
18. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
Kraus WL; Katzenellenbogen BS
Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742
[TBL] [Abstract][Full Text] [Related]
19. The antiestrogen LY117018 is estrogenic in the fetal rat.
Henry EC; Miller RK
Teratology; 1986 Aug; 34(1):59-63. PubMed ID: 3764778
[TBL] [Abstract][Full Text] [Related]
20. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
